Yizhao Chen

Dominant negative TGF-β receptor type II in T lymphocytes promotes anti-tumor immunity by modulating T cell subsets and enhancing CTL responses.

Hao Li, Wei Wei, Li-Qun Jiang, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

CAR-macrophage: A new immunotherapy candidate against solid tumors.

Wei Wei, Wenming Hong, Jiajie Tu, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.

Wenming Hong, Jiajie Tu, Yizhao Chen, 2023, Life sciences.

Clinical application of VATS combined with 3D-CTBA in anatomical basal segmentectomy

Lening Zhang, Yizhao Chen, Chunshan Han, 2023, Frontiers in Oncology.

PU.1 promotes development of rheumatoid arthritis via repressing FLT3 in macrophages and fibroblast-like synoviocytes

Wei Wei, Wenming Hong, Xinming Wang, 2022, Annals of the Rheumatic Diseases.

The application of HER2 and CD47 CAR-macrophage in ovarian cancer

Wenming Hong, Jiajie Tu, Yizhao Chen, 2023, Journal of Translational Medicine.

CAR-T therapy for ovarian cancer: Recent advances and future directions.

Yizhao Chen, Qian Xin, Xiaojing Sun, 2024, Biochemical pharmacology.

Developing CAR-immune cell therapy against SARS-COV-2: Current status, challenges, and prospects.

Jiajie Tu, Yizhao Chen, Weile Chen, 2024, Biochemical pharmacology.

Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development.

Xinming Wang, Jiajie Tu, Yizhao Chen, 2024, Annals of the rheumatic diseases.